Welcome to our dedicated page for Scilex Holding Co news (Ticker: SCLX), a resource for investors and traders seeking the latest updates and insights on Scilex Holding Co stock.
Scilex Holding Company (Nasdaq: SCLX) generates frequent news at the intersection of non-opioid pharmaceuticals, capital markets activity, and emerging data-tokenization initiatives. The company focuses on acquiring, developing and commercializing non-opioid pain management products for acute and chronic pain and for neurodegenerative and cardiometabolic disease, and its updates often center on this portfolio and related strategic moves.
News about Scilex commonly covers developments around its commercial products ZTlido, ELYXYB and Gloperba, as well as its late-stage candidates SP-102 (SEMDEXA), SP-103 and SP-104. Company announcements highlight clinical milestones, regulatory designations such as Fast Track status for certain candidates, and efforts to advance non-opioid therapies in indications with high unmet needs.
Investors following SCLX news will also see regular coverage of financing and corporate transactions. Recent Form 8-K filings and press releases describe warrant inducement agreements, exercises of existing warrants for cash proceeds, issuance of new warrants, non-recourse loan and securities pledge agreements backed by Scilex or Datavault AI shares, and the termination of an equity line of credit. These items provide insight into how Scilex structures its capital and manages liquidity.
Another recurring news theme is Scilex’s collaboration with Datavault AI. Announcements describe a Securities Purchase Agreement for Datavault AI stock, a pre-funded warrant, and a License Agreement for Datavault’s AI-driven data platforms in biotech and related markets. Press releases also detail Dream Bowl 2026 Meme Coin distributions by Datavault AI to eligible Scilex shareholders and Scilex’s sponsorship of the Dream Bowl 2026 event.
Visitors to this news page can review regulatory disclosures, financing updates, licensing and investment agreements, digital asset-related announcements, and other material events reported in Scilex’s press releases and SEC filings.
Scilex Holding Company (Nasdaq: SCLX) announced on Jan 2, 2026 the appointment of Kasowitz LLP and founding partner Marc Kasowitz as its litigation and intellectual property counsel. Kasowitz LLP will advise on complex commercial and patent litigation, IP enforcement and defense, licensing, and strategic IP governance as Scilex advances and protects its pharmaceutical assets and late-stage development pipeline.
A Scilex spokesperson said the appointment strengthens legal capabilities to support commercialization and shareholder value. Company product websites and contact information were provided.
Scilex Holding Company (Nasdaq: SCLX) confirmed a Dream Bowl 2026 Meme Coin claim process tied to a December 24, 2025 distribution. Eligible shareholders of record as of November 25, 2025 may claim allocated tokens any time after the December 24, 2025 distribution using the designated process at www.dreambowlcoin.com. The token program is powered by Datavault AI using encrypted blockchain infrastructure and real-world asset tokenization. The announcement positions the meme coin as a fusion of sports, digital assets, and shareholder perks. For corporate and product information, Scilex directs investors to its corporate and product websites.
Scilex Holding Company (Nasdaq: SCLX) closed the second tranche of its strategic investment in Datavault AI (Nasdaq: DVLT) on Nov 26, 2025, completing a two‑tranche equity financing.
Scilex purchased a pre‑funded warrant exercisable for 263,914,094 shares of Datavault common stock, paid in Bitcoin based on the spot rate at signing, and has exercised the warrant in full.
The shares issued upon exercise have an approximate value of $583.3 million based on Datavault's closing price of $2.21 on Nov 25, 2025. Datavault stockholder approval was obtained at the Nov 24, 2025 annual meeting. Both companies plan to ramp collaboration on Real World Asset tokenization in 2026.
Scilex Holding Company (Nasdaq: SCLX) announced the closing of reduced-price exercises of existing warrants, generating approximately $20.3 million gross proceeds on Nov 25, 2025. The exercises converted 904,396 shares of common stock at a reduced $22.51 per share.
In exchange, the company issued a new unregistered warrant to purchase up to 1,356,594 shares at a $29.00 exercise price, exercisable immediately for five years. Net proceeds are expected to be used for working capital and general corporate purposes.
Scilex Holding Company (Nasdaq: SCLX) announced a definitive agreement for the cash exercise of existing warrants to purchase an aggregate of 904,396 shares of common stock, generating approximately $20.3 million in gross proceeds before placement agent fees and offering expenses.
In exchange for immediate cash exercise, the company will issue a new unregistered warrant to purchase up to 1,356,594 shares at an exercise price of $29.00 per share, exercisable immediately with a five-year term. The offering is expected to close on or about November 25, 2025, and net proceeds are planned for working capital and general corporate purposes.
Scilex Holding Company (Nasdaq: SCLX) said Datavault AI (Nasdaq: DVLT) intends to voluntarily distribute Dream Bowl 2026 Meme Coins to Scilex record holders as of November 25, 2025, concurrent with Datavault AI's own eligible holders.
Nasdaq told Datavault AI it will not make an announcement for Scilex about the distribution date. Distribution is conditional on recipients opting in, setting up a Data Vault® wallet, and providing documentation. Datavault AI's board may change the record date and will set the payment date within 60 days after the record date; payment is conditioned on the board not revoking the distribution.
Scilex Holding Company (Nasdaq: SCLX) said Datavault AI (Nasdaq: DVLT) approved a distribution of a Dream Bowl 2026 Meme Coin to eligible Scilex and Datavault AI stockholders.
Key mechanics: the record date is November 25, 2025, the ex-dividend date is November 24, 2025, and holders of record will receive one Dream Bowl 2026 Meme Coin per share. Datavault AI plans to airdrop handcrafted digital coins into Data Vault wallets and will collect shareholder wallet info; distribution begins on or after December 8, 2025. Datavault may revoke or change the distribution or record date; the Payment Date will be set within 60 days after the record date.
The Dream Bowl event is scheduled for January 11, 2026 at AT&T Stadium and will include drone racing and e-sports championships.
Scilex Holding Company (Nasdaq: SCLX) announced a worldwide exclusive license, with sublicense rights, to Datavault AI’s AI-driven technology to build a Biotech Exchange for tokenizing, trading and monetizing biotech assets including genomic, DNA, diagnostic, therapeutic and drug data.
The agreement includes a non-refundable upfront license fee payable in four equal installments of $2.5 million (totaling $10.0 million) due by September 30, 2026 and contingent sales milestone payments of up to $2.55 billion. The license covers a portfolio of issued and pending patents, including key pending U.S. application 17/941,623 for tokenizing DNA data.
Scilex Holding Company (Nasdaq: SCLX) announced it will sponsor Dream Bowl 2026 and set a record date of November 14, 2025 for shareholders to receive a Dream Bowl 2026 meme coin distributed by DataVault AI. Shareholders of record on November 14, 2025 will receive one meme coin per common share. Handcrafted digital coins will be airdropped to Data Vault wallets on or after November 25, 2025. The Dream Bowl event is scheduled for January 11, 2026 at AT&T Stadium in Dallas, with additional drone racing and e-sports championships included.
Scilex Holding Company (Nasdaq: SCLX), a non-opioid pain management company, has completed the first tranche of its warrant repurchase agreement with Oramed Pharmaceuticals. The company has repurchased 3,130,000 warrants at $0.01 exercise price for $13 million.
Under the previously disclosed option agreement, Scilex has the right to repurchase a total of 6,500,000 warrants in two tranches for a total of $27 million. The company retains the option to repurchase the remaining 3,370,000 warrants for $14 million before December 31, 2025.
FAQ
What is the current stock price of Scilex Holding Co (SCLX)?
What is the market cap of Scilex Holding Co (SCLX)?
